At present, the development of those solutions is hindered by slow, expensive, and overly complex lab workflows.
We are dedicated to developing a platform that integrates robotics, software, assay development, and lab operations to supercharge the pace of innovation in life sciences.
We build state-of-the-art labs from the ground up with custom automation, software, and assays.
We supply lab services to healthcare systems, offering affordable, high-throughput solutions for molecular diagnostics.
We offer genome-scale cell engineering solutions for biopharma, enabling the development of novel therapeutics.
We create flexible, easy-to-use robotics to help life science labs in academia and industry automate their operations.
- John BadalCEO, Opentrons Labworks, Inc.
- Eva BorattoCFO, Opentrons Labworks, Inc
- Veleka Peeples-DyerChief Legal Officer, Corporate Secretary and Chief Compliance Officer, Opentrons Labworks, Inc
- David KimGM, Opentrons Robotics
- Neil RobertsonCEO, ZenithAI
- Leslie MitchellCEO, Neochromosome, Inc
- Myrtle PotterChair of the Board, Opentrons Labworks, Inc
- Robert S. LangerHead of Scientific Advisory Board, Neochromosome, Inc
- Jef BoekeHead of Scientific Advisory Board, PRL
- Greg GreeleyAdvisor, Opentrons Labworks, Inc
- Angela DuMember of the Board, Opentrons Labworks, Inc
- Eric HippeauMember of the Board, Opentrons Labworks, Inc
- Sven StrohbandMember of the Board, Opentrons Labworks, Inc
This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.
